Arterial Revascularization Trial (ART): What does it mean?
2,698 views · Published 26 October 2018 · 7:23 · Indexed 3 October 2026
Channel: Cleveland Clinic · 2018 · Science & Technology
Dr. Faisal Bakaeen, Director of Cleveland Clinic's Coronary Artery Bypass Surgery Center discusses the findings of the ART trial, which showed no difference in the composite end point of death, myocardial infarction or stroke between the BITA (bilateral internal thoracic artery) and SITA (single internal thoracic artery) for coronary artery bypass graft surgery. He provides an explanation of the findings and encourages tailoring the surgery to the patient. Use of multi-arterial coronary artery bypass grafts for the right patient can provide the best long term outcomes. Learn more about this topic on ConsultQD.https://consultqd.clevelandclinic.org/what-the-arterial-revascularization-trial-says-about-surgeon-experience-and-cabg-success/
More from this channel
-
2:06
Kidney transplant ends seven years of dialysis
-
1:21
Critical Care Transport Overview
-
4:13
Cancer Survivor - Nancy Collot - From Cancer Diagnosis to Wellness
-
2:24
PAP Therapy: Choosing the Right Mask
-
0:39
PAP Therapy: Choosing a machine
-
0:46
Women and Bone Health
-
1:27
PSA Test Saves Mans Life
-
1:17
What is Epilepsy